HIV Clinical Trials

101 studies are recruiting for hiv in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 3

  1. Inflammation and Depression in People With HIV

    The purpose of this 10-week, double-blind, placebo-controlled study is to determine whether inflammation impacts reward and motor neural circuitry to contribute to depressive symptoms like anhedonia and psychomotor slowing in people with Human Immunodeficiency Virus (HIV) and depression. Sixty male…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Grady Memorial Hospital, Atlanta, Georgia
    Locations
    2 in total
    Run by
    Emory University
  2. GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

    The goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are: 1. Does semaglutide lower the average number of alcoholic beverages participants drink per week? 2. Does semaglutide lower the a…

    Stage
    Phase 2
    Ages
    18 to 89
    Site
    Vanderbilt University Medical Center, Nashville, Tennessee
    Run by
    Vanderbilt University Medical Center
  3. Gathering Online for Dialogue and Discussion to Enhance Social Support

    The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with up to 500 young women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol. The expected outcomes are to…

    Stage
    Not phased
    Ages
    18 to 30
    Site
    RTI International, Durham, North Carolina
    Run by
    RTI International
  4. Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

    The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART (antiretroviral therapy)…

    Stage
    Not phased
    Ages
    13 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham
  5. The Collaborative Care PrTNER Study

    A randomized controlled trial to assess the ability of a Collaborative Care Prevention, Treatment, Navigation, Engagement, Resource (PrTNER) intervention to increase initiation of preexposure prophylaxis (PrEP) (for those at-risk for HIV) and decrease viral load (for those living with HIV) among yo…

    Stage
    Not phased
    Ages
    15 to 29
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    2 in total
    Run by
    Children's Hospital of Philadelphia
  6. Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men

    The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, includi…

    Stage
    Not phased
    Ages
    16 to 34
    Site
    Northwestern University, Chicago, Illinois
    Run by
    Northwestern University
  7. PrEP Readiness Interventions for Sustained Motivation (PRISM)

    This is a hybrid type I randomized controlled trial to test the effectiveness of contingency management (CM) alone versus CM with motivational interviewing (MI) for optimizing entry or re-entry into the HIV prevention or care continua. A total of 400 participants will be randomized to CM (n = 200) …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Florida International University, Miami, Florida
    Run by
    Florida International University
  8. A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

    This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreene…

    Stage
    Not phased
    Ages
    15 to 26
    Site
    Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, Louisiana
    Run by
    Tulane University
  9. The Use of Leukapheresis to Support HIV Pathogenesis Studies

    Despite the dramatic improvements that have resulted from combination antiretroviral treatment, long-term efficacy, toxicity, cost, and the requirements for life-long adherence remain as formidable challenges. Also, there is emerging consensus that persistent HIV-associated disease occurs during lo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    San Francisco General Hospital, San Francisco, California
    Run by
    University of California, San Francisco
  10. The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

    HIV medicines have led to dramatic improvements in health. However, there remains a concern for potential drug toxicities, cost of drugs, and need for life-long treatment. In addition, research has found that health is not completely restored in HIV-infected patients, even if they have been taking …

    Stage
    Not phased
    Ages
    18 to 70
    Site
    San Francisco General Hospital, San Francisco, California
    Run by
    University of California, San Francisco
  11. Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

    This study has the potential to contribute to a more complete understanding of the independent and combined effects of cannabis use and HIV on the brain and on inflammation. Such knowledge may inform future strategies for treating brain disease and inflammation. Participants will be randomly assign…

    Stage
    Phase 2
    Ages
    21 to 70
    Site
    HIV Neurobehavioral Research Program (HNRP), San Diego, California
    Run by
    University of California, San Diego
  12. 1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV

    This study tests a 5-session cognitive behavioral approach program (herein referred to as the 1MoreStep intervention) to train Black women living with HIV (BWLWHI) and exposed to intimate partner violence (IPV) in the past 2 years (hereafter, BWLWHI) in: 1) cognitive and behavioral skills to access…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Johns Hopkins School of Nursing, Baltimore, Maryland
    Run by
    Johns Hopkins University
  13. Stress and Pain in People Living With HIV

    This is a basic human experimental study utilizing 4 groups of individuals with and without HIV and complex morbidities of cannabis use disorder and major depression who will participate in 2 sessions of the Yale Pain Stress Task (YPST) and follow-up phase to assess drug use and mood symptoms.

    Stage
    Not phased
    Ages
    18 to 68
    Site
    The Yale Stress Center, New Haven, Connecticut
    Run by
    Yale University
  14. Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

    This randomized clinical trial (RCT) evaluates whether metformin can reduce systemic inflammation and improve immune function in individuals with a history of injection drug use, with or without HIV. Participants will receive metformin or placebo and undergo immune system assessments, including vac…

    Stage
    Phase 4
    Ages
    18 to 64
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham
  15. The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women

    Menopause is associated with the acceleration of many comorbidities, including cardiovascular disease. Whether HIV and menopause together increase cardiovascular disease risk is a key knowledge gap. The goal of this observational study is to address this knowledge gap by looking at the role of meno…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco
  16. Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

    Cigarette smoking is now the leading killer of people with HIV (PWH) in the US, and most cessation strategies tried to date have failed to increase long-term quit rates. An "all or none" approach to smoking cessation in PWH offers little benefit to the large majority of PWH who are unable or unwill…

    Stage
    Not phased
    Ages
    40 to 79
    Site
    Montefiore Medical Center, The Bronx, New York
    Run by
    Montefiore Medical Center
  17. J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations

    The goal of this clinical trial is to compare two interventions - Health Navigation and Health Navigation Plus among individuals who have been impacted by the criminal legal system. The main question it aims to answer is: • Compared with the Health Navigation group, are participants in the Health N…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  18. Ending the HIV Epidemic: An All-facility Intervention for Patient and Healthcare Staff Well-being

    The scope of this study is to engage Ryan White HIV/AIDS Program (RWHAP) funded organizations in the South/East US to co-develop context-responsive programs utilizing evidence-informed interventions to reduce stigma against living with HIV (PLH) who have difficulties accessing and remaining engaged…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Columbia University School of Nursing, New York, New York
    Run by
    Columbia University
  19. Finishing HIV Project

    This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.

    Stage
    Not phased
    Ages
    18 to 54
    Site
    University of Miami, Miami, Florida
    Run by
    University of Miami
  20. Collection of Blood for Multiple Collaborative Studies

    This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

    Stage
    Not phased
    Ages
    18 and older
    Site
    San Francisco General Hospital, San Francisco, California
    Run by
    University of California, San Francisco
  21. Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men

    The goal of this observational study is to learn about the pilot test of the employment program among young Black sexual minority men. The main question it aims to answer is: What is the feasibility and acceptability of the employment program? Young Black sexual minority male participants will atte…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  22. Enhancing Wellness Through Affirming Services and Education

    The goal of this treatment study is to learn about the mental health, substance use and physical health outcomes associated with participating in the EASE holistic behavioral health and wellness program for individuals seeking HIV prevention and/or living with HIV. The main questions it aims to ans…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Susan Reif, Charlotte, North Carolina
    Run by
    Duke University
  23. Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

    This study applies a hypothesis-driven approach to examine the effects of chronic marijuana use on HIV-associated inflammation and its subsequent impacts on central nervous system function, with the goal of identifying the mechanisms through which cannabinoids modulate neurological disorders and ot…

    Stage
    Not phased
    Ages
    25 to 59
    Site
    Biotech Place, Winston-Salem, North Carolina
    Run by
    Wake Forest University Health Sciences
  24. Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

    This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reduc…

    Stage
    Phase 2
    Ages
    18 to 99
    Site
    Atlanta VA Medical Center, Decatur, Georgia
    Run by
    Yale University
  25. Transitional Housing and HIV Health

    The goal of this pilot study is to evaluate the implementation and outcomes of the Arms Around You (AAY) program, a supportive housing initiative launched by the Philadelphia Department of Public Health (PDPH) in 2024. The program aims to address housing instability among people with HIV (PWH) usin…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    2 in total
    Run by
    University of Pennsylvania

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.